astrazeneca absci financialtimes

astrazeneca absci financialtimes pepe unchain Bnb Eth XRP crypto futures coinbase futures binance futures

What is AstraZeneca's deal with absci worth?

Photo: Mikael Sjoberg/Bloomberg via Getty Images. Pharmaceuticals giant AstraZeneca has closed on a deal with US-based biotech AbSci Corporation to develop an antibody therapy for an undisclosed cancer using Absci’s AI technology. The deal, signed yesterday (3 November), is worth up to $247m, according to the Financial Times.

How will AstraZeneca collaborate with absci?

This collaboration combines Absci’s Integrated Drug Creation™ platform with AstraZeneca’s expertise in oncology with the goal of accelerating the discovery of a potential new cancer treatment candidate. Absci will contribute its pioneering generative AI technology to deliver a therapeutic candidate antibody for a specified oncology target.

What is AstraZeneca's $247m deal with absci?

The $247m deal will focus on the use of generative artificial intelligence to develop an antibody therapy for an unnamed cancer. AstraZeneca has signed a deal with US biopharma Absci. Photo: Mikael Sjoberg/Bloomberg via Getty Images.

Can Moo Deng Hit $10? Moo Deng (MOODENG) Price Prediction 2024, 2025 20302024-12-03 10:39:58  A new meme coin called Moo Deng is based on the […]

Pepe Unchained ($PEPU) Meme Coin Review & Analysis: Pepe Unchained Presale Hits $66 Million With Just 10 Days Left Before Possible Tier 1 Listings2024-12-03 09:20:40Following Donald Trump’s epic victory in US election, […]